# US 2024/0390407 A1 · Promoter for differentiation into cartilage cell, cartilage cell propagation promoter, and cartilage matrix production promoter

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0390407 A1
- Document ID: US20240390407A1
- Status: Published application
- Kind: A1
- Application number: 18/692,618
- Filed: 2022-09-16
- Published: 2024-11-28
- Earliest claimed: 2021-09-17
- Assignees: Hokuriku University; Cokey Systems Co., Ltd.
- Applicants: Hokuriku University; Cokey Systems Co., Ltd.
- Inventors: Masakazu MIURA; Tatsuo TAKAHASHI; Hirokazu SUZUKI; Nobuji YOSHIKAWA
- Web page: https://patentgrep.com/patent/US20240390407A1

## CPC

- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A23L 33/125: containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21)
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12N 5/0655: {Chondrocytes; Cartilage}
- C12N 2500/30: Organic components
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to promoters for differentiation into chondrocytes, chondrocyte proliferation promoter, and cartilaginous matrix production promoter, each containing a glycoside of liquiritigenin. According to the present invention, promoters for differentiation into chondrocytes, promoters for proliferation of chondrocytes, and promoters for cartilaginous matrix production, that are superior in the stability and safety, have a superior promoting action on differentiation into chondrocytes, a superior promoting action on proliferation of chondrocytes, and a superior promoting action on cartilaginous matrix production, and effective for regeneration of cartilage and further, prophylaxis or improvement of symptoms and diseases caused by the damage and inflammation of cartilage, or symptoms and diseases showing the loss of cartilage such as osteoarthritis and the like.

## Claims

### Claim 1

A promoter for differentiation into chondrocytes, comprising a glycoside of liquiritigenin.

### Claim 2 (depends on 1)

The promoter according to claim 1, wherein the glycoside of liquiritigenin is liquiritin.

### Claim 3

A promoter for chondrocyte proliferation, comprising a glycoside of liquiritigenin.

### Claim 4 (depends on 3)

The promoter according to claim 3, wherein the glycoside of liquiritigenin is liquiritin.

### Claim 5

A cartilaginous matrix production promoter comprising a glycoside of liquiritigenin.

### Claim 6 (depends on 5)

The promoter according to claim 5, wherein the glycoside of liquiritigenin is liquiritin.

### Claim 7

A cartilage regenerant comprising a glycoside of liquiritigenin.

### Claim 8 (depends on 7)

The regenerant according to claim 7, wherein the glycoside of liquiritigenin is liquiritin.

### Claim 9 (depends on 1)

A pharmaceutical product for the prophylaxis or improvement of a symptom or disease caused by damage or inflammation of cartilage, or a symptom or disease showing the loss of cartilage, comprising the differentiation promoter according to claim 1.

### Claim 10 (depends on 9)

The pharmaceutical product according to claim 9, wherein the symptom or disease caused by damage or inflammation of cartilage, or the symptom or disease showing the loss of cartilage is osteoarthritis.

### Claim 11 (depends on 3)

A pharmaceutical product for the prophylaxis or improvement of a symptom or disease caused by damage or inflammation of cartilage, or a symptom or disease showing the loss of cartilage, comprising the proliferation promoter according to claim 3.

### Claim 12 (depends on 11)

The pharmaceutical product according to claim 11, wherein the symptom or disease caused by damage or inflammation of cartilage, or the symptom or disease showing the loss of cartilage is osteoarthritis.

### Claim 13 (depends on 5)

A pharmaceutical product for the prophylaxis or improvement of a symptom or disease caused by damage or inflammation of cartilage, or a symptom or disease showing the loss of cartilage, comprising the production promoter according to claim 5.

### Claim 14 (depends on 13)

The pharmaceutical product according to claim 13, wherein the symptom or disease caused by damage or inflammation of cartilage, or the symptom or disease showing the loss of cartilage is osteoarthritis.

### Claim 15 (depends on 1)

A food for the prophylaxis or improvement of a symptom or disease caused by damage or inflammation of cartilage, or a symptom or disease showing the loss of cartilage, comprising the differentiation promoter according to claim 1.

### Claim 16 (depends on 15)

The food according to claim 15, wherein the symptom or disease caused by damage or inflammation of cartilage, or the symptom or disease showing the loss of cartilage is osteoarthritis.

### Claim 17 (depends on 3)

A food for the prophylaxis or improvement of a symptom or disease caused by damage or inflammation of cartilage, or a symptom or disease showing the loss of cartilage, comprising the proliferation promoter according to claim 3.

### Claim 18 (depends on 17)

The food according to claim 17, wherein the symptom or disease caused by damage or inflammation of cartilage, or the symptom or disease showing the loss of cartilage is osteoarthritis.

### Claim 19 (depends on 5)

A food for the prophylaxis or improvement of a symptom or disease caused by damage or inflammation of cartilage, or a symptom or disease showing the loss of cartilage, comprising the production promoter according to claim 5.

### Claim 20 (depends on 19)

The food according to claim 19, wherein the symptom or disease caused by damage or inflammation of cartilage, or the symptom or disease showing the loss of cartilage is osteoarthritis.
